NASDAQ
Alseres Pharmaceuticals, Inc. (ALSE) has a price/sales ratio of 1.52x as of Friday, May 22, 2026. This represents a 558.18% increase compared to its 12-month average of 0.23x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.